List of works - Marcella Manerba

Albumin-drug conjugates in the treatment of hepatic disorders.

scientific article published on 29 April 2014

Altered glycosylation profile of purified plasma ACT from Alzheimer's disease

scientific article published on 16 December 2010

Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy

scientific article published on 18 August 2009

Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons

scientific article published in April 2009

Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells

scientific article published on 10 September 2011

Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.

scientific article

Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.

scientific article published on September 2013

Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways ⬇️

scientific article published on August 30, 2012

Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.

scientific article

Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.

scientific article published on 10 August 2010

Inhibition of lactate dehydrogenase activity as an approach to cancer therapy

scientific article

Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors.

scientific article published on 17 December 2010

Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment

scientific article published on 7 April 2016

Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells

scientific article

Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes

scientific article published on 28 April 2015

NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases

scientific article published on January 2013

Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A.

scientific article published on 9 November 2016

List of works by Marcella Manerba

Albumin-drug conjugates in the treatment of hepatic disorders.

Altered glycosylation profile of purified plasma ACT from Alzheimer's disease

Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy

Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons

Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells

Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.

Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.

Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways ⬇️

Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.

Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.

Inhibition of lactate dehydrogenase activity as an approach to cancer therapy

Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors.

Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment

Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells

Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes

NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases

Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A.